|
Real-time Estimate
Cboe BZX
23:50:44 11/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 319.03 USD | -0.60% |
|
-3.84% | -5.77% |
| 09-09 | Cencora's MWI Animal Health Merger With Covetrus Sees 'Intensified' FTC Scrutiny, RBC Says | MT |
| 09-08 | Cencora, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 09:30 AM |
| Market Cap | 61.25B 52.67B 49.7B 45.27B 84.63B 5,856B 85.4B 592B 228B 2,970B 230B 225B 9,434B | P/E 2026 * |
17.6x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 68.94B 59.29B 55.94B 50.96B 95.26B 6,591B 96.13B 666B 256B 3,343B 259B 253B 10,618B | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.2x |
| Free-Float |
61.21% | Yield 2026 * |
0.74% | Yield 2027 * | 0.76% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
Boerse Muenchen
| ABG | Real-time | |
|
London S.E.
| 0HF3 | Delayed | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript : Cencora, Inc.
| 1 day | -0.56% | ||
| 1 week | -3.84% | ||
| Current month | -1.65% | ||
| 1 month | -4.68% | ||
| 3 months | +13.06% | ||
| 6 months | -9.15% | ||
| Current year | -5.77% |
| 1 week | 318.1 |  | 330 |
| 1 month | 302.01 | | 338.71 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 172.41 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 01/10/2024 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 29/06/2026 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 16/05/2013 |
Robert Mauch
BRD | Director/Board Member | 59 | 01/10/2024 |
D. Mark Durcan
CHM | Chairman | 64 | 01/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Sell | Controller/Auditor | -985 | 0.0005% | ||
| 24/8/26 | Sell | General Counsel | -11,300 | 0.0058% | ||
| 31/7/26 | Free | Director | 97 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | -3.84% | +5.10% | +79.06% | 61.25B | |
| -1.36% | -6.05% | -23.28% | -0.66% | 179B | |
| -1.29% | -4.00% | -4.08% | +11.06% | 117B | |
| -1.92% | -7.24% | +9.51% | +41.28% | 50.24B | |
| -0.48% | -4.99% | -7.90% | -34.31% | 48.05B | |
| -1.28% | -5.34% | +9.49% | -22.44% | 31.89B | |
| -0.29% | -12.00% | - | - | 28.42B | |
| +1.26% | +2.46% | +32.07% | -12.29% | 24.23B | |
| +0.49% | -8.98% | -13.28% | +5.27% | 21.4B | |
| +0.32% | -1.79% | +10.43% | -28.34% | 21.08B | |
| Average | -0.52% | -5.28% | +2.01% | +4.29% | 58.26B | |
| Weighted average by Cap. | -0.94% | -4.31% | -5.80% | +8.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 290B 274B 249B 466B 32,236B 470B 3,258B 1,254B 16,351B 1,266B 1,238B 51,934B | 353B 304B 287B 261B 488B 33,760B 492B 3,412B 1,313B 17,124B 1,326B 1,297B 54,390B |
| Net income | 3.58B 3.08B 2.91B 2.65B 4.95B 342B 4.99B 34.6B 13.32B 174B 13.44B 13.15B 551B | 2.84B 2.45B 2.31B 2.1B 3.93B 272B 3.97B 27.49B 10.58B 138B 10.68B 10.45B 438B |
| Net Debt | 7.69B 6.61B 6.24B 5.68B 10.63B 735B 10.72B 74.32B 28.6B 373B 28.88B 28.25B 1,185B | 9.44B 8.12B 7.66B 6.98B 13.04B 902B 13.16B 91.19B 35.1B 458B 35.44B 34.66B 1,454B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$318.10 | -0.89% | 199,500 |
| 10/09/26 | US$320.95 | -0.73% | 1,346,332 |
| 09/09/26 | US$323.32 | -0.42% | 1,215,502 |
| 08/09/26 | US$324.69 | -1.89% | 2,200,493 |
| 04/09/26 | US$330.95 | -1.86% | 1,027,638 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
